NASDAQ:GLYC - Nasdaq - US38000Q1022 - Common Stock - Currency: USD
TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 10.00K | 10.00K | 80.00K | 1.16M | 10.16M | |||
Operating Expenses | 40.88M | 39.29M | 47.48M | 64.61M | 61.67M | |||
Research and Development | 22.89M | 20.07M | 28.39M | 47.49M | 44.93M | |||
Selling, General, and Administrative Expenses | 17.99M | 19.21M | 19.09M | 17.12M | 16.74M | |||
Operating Income | -40.87M | -39.28M | -47.40M | -63.45M | -51.51M | |||
Interest Income/Expense | 1.76M | 2.38M | 710.00K | 20.00K | 480.00K | |||
Income Before Taxes | -39.11M | -36.90M | -46.69M | -63.43M | -51.03M | |||
Income Tax | N/A | N/A | N/A | N/A | N/A | |||
Net Income | -39.11M | -36.90M | -46.69M | -63.43M | -51.03M | |||
EBITDA | -40.78M | -39.12M | -47.19M | -63.19M | -51.24M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.60 | -0.58 | -0.89 | -1.23 | -1.12 | |||
Non GAAP EPS | -0.61 | -0.58 | -0.88 | -1.23 | -1.11 | |||
Statistics | ||||||||
Profit Margin | -391107.20% | -368994.20% | -58362.50% | -5468.10% | -502.26% | |||
Operating Profit Margin | -408735.50% | -392752.90% | -59250.00% | -5469.83% | -506.99% |
All data in USD